SearchBar Icon

Global Neurostimulation Device Market (Size of $5,656.1 million in 2015) to Witness 12.9% CAGR During 2016 – 2022

Published Date:   July 2016

The global neurostimulation device market was valued at $5,656.1 million in 2015, and it is expected to grow at a CAGR of 12.9% during the period 2016 - 2022. The neurostimulation device market is growing, due to increasing geriatric population, increasing prevalence of chronic pain, and increasing incidents of neurological disorders. In addition, the awareness about mental diseases and their treatment is also increasing across the globe.

Explore Report with Detailed TOC on “Global Neurostimulation Device Market” at:

Among the different types of neurostimulation devices, the implantable/interna neurostimulation segment is expected to witness the faster growth during the forecast period. Among the various applications, the pain management segment held the largest share in the global neurostimulation device market in 2015, and it is expected to witness the fastest growth during the forecast period.

The information and data in the publication “Global Neurostimulation Device Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the research and analysis of data from various primary and secondary sources. The top-down approach has been used to calculate the global neurostimulation device market size by type, and application. The market numbers for countries are obtained through top-down approach. P&S Intelligence analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in the report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.

The prevalence of chronic pain and neurological disorders is increasing globally, due to which the demand for better neurostimulation device is increasing. As a result, the research and development (R&D) investments in the development of novel and innovative neurostimulation devices are growing. The aim of increasing R&D investments in neurostimulation device is to offer better safety and efficacy to the patients. Moreover, the demand for minimally-invasive treatments is also growing in order to minimize pain and discomfort. As a result, the demand for new and effective medical technologies is expected to increase for the treatment of various neurological disorders.

Some of the key companies operating in the global neurostimulation device market include Aleva Neurotherapeutics SA, St. Jude Medical Inc., Medtronic PLC, Boston Scientific Corporation, LivaNova PLC, Cochlear Ltd., Neuropace Inc., Neurosigma Inc., MED-EL GmbH, Synapse Biomedical Inc., Neuronetics Inc., NDI Medical LLC, EnteroMedics Inc., and ImThera Medical.

By Type

  • Implantable/Internal Neurostimulation Device Market
    • Spinal cord stimulation (SCS) device market
    • Deep brain stimulation (DBS) device market
    • Sacral nerve stimulation (SNS) device market
    • Vagus nerve stimulation (VNS) device market
    • Cochlear implants (CI) device market
    • Gastric electric stimulation (GES) device market
  • External Neurostimulation Device Market
    • Transcutaneous electrical nerve stimulation (TENS) market
    • Transcranial magnetic stimulation (TMS) device market

By Application

  • Pain Management Neurostimulation Device Market
  • Parkinson’s Disease Neurostimulation Device Market
  • Neurologic Urinary and Fecal Incontinence Neurostimulation Device Market
  • Epilepsy Neurostimulation Device Market
  • Hearing Loss Neurostimulation Device Market
  • Gastroparesis Neurostimulation Device Market
  • Depression Neurostimulation Device Market

By Geography

  • North America- U.S., Canada, and Rest of North America
  • Europe- U.K., Germany, France, and Rest of Europe
  • Asia - China, Japan, India, and Rest of Asia
  • Rest of the World (RoW)- Brazil, Australia and Rest of Rest of the World